Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
34.26
+0.96 (+2.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
33
34
Next >
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
↗
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
↗
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
3 Biotech Moonshots With Imminent Catalyst Potential
↗
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Clinical-state biopharmaceutical company Altimmune Inc. (NASDAQ: ALT) focuses on developing peptide-based therapeutics for obesity and chronic liver diseases
Via
MarketBeat
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
↗
July 01, 2024
Via
Benzinga
Viking Therapeutics Unusual Options Activity For June 25
↗
June 25, 2024
Via
Benzinga
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy
Via
MarketBeat
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via
MarketBeat
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
↗
July 01, 2024
It's a tough act to follow.
Via
The Motley Fool
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
↗
June 30, 2024
While their share prices have traveled different paths recently, the similarity between the two companies is striking.
Via
The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $600 Today
↗
June 18, 2024
Via
Benzinga
Viking Therapeutics Unusual Options Activity For June 12
↗
June 12, 2024
Via
Benzinga
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
↗
June 28, 2024
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.
Via
InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
↗
June 28, 2024
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector.
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
↗
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years.
Via
The Motley Fool
Better Growth Stock: Archer Aviation or Viking Therapeutics?
↗
June 26, 2024
Which one of these potential disruptors is the better buy?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
June 25, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 24, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
↗
June 18, 2024
This stock may not be a slam dunk, but it's looking very promising.
Via
The Motley Fool
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
↗
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
↗
June 15, 2024
There's a lot of hope for these stocks, but there's also a fair amount of risk.
Via
The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
↗
June 15, 2024
Just because a stock has amazing growth prospects doesn't mean you should ignore its valuation.
Via
The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
↗
June 14, 2024
Novo Nordisk's competition in the obesity drug market is heating up.
Via
The Motley Fool
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
↗
June 13, 2024
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
June 13, 2024
Via
Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
↗
June 13, 2024
One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity.
Via
InvestorPlace
Topics
Artificial Intelligence
3 Stocks Quietly Preparing for a 10X Surge: June Edition
↗
June 12, 2024
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.
Via
InvestorPlace
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
↗
June 10, 2024
The company is focusing on obesity treatment after its glaucoma drug failed.
Via
Investor's Business Daily
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
↗
June 10, 2024
Success isn't guaranteed, but both companies could become big winners.
Via
The Motley Fool
This High-Flying Stock Just Announced More Good News: Time to Buy?
↗
June 09, 2024
The biotech's prospects keep getting brighter.
Via
The Motley Fool
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
